Pilot trial of a group cognitive behavioural therapy program for comorbid depression and obesity.

South Australian Health and Medical Research Institute, Adelaide, SA, 5001, Australia.South Australian Health and Medical Research Institute, Adelaide, SA, 5001, Australia.CALHN, Royal Adelaide Hospital, Adelaide, SA, 5000, Australia.CALHN, Royal Adelaide Hospital, Adelaide, SA, 5000, Australia.College of Medicine, SUNY Upstate Medical University, Syracuse, NY, 13210, USA. PerrySe@upstate.edu.College of Medicine, SUNY Upstate Medical University, Syracuse, NY, 13210, USA.College of Medicine, SUNY Upstate Medical University, Syracuse, NY, 13210, USA.

BMC psychology. 2020;(1):34
Full text from:

Abstract

BACKGROUND Depression and obesity are significant global health concerns that commonly occur together. An integrated group cognitive behavioural therapy program was therefore developed to simultaneously address comorbid depression and obesity. METHODS Twenty-four participants (63% women, mean age 46 years) who screened positively for depression with a body mass index ≥25 were recruited from a self-referred general population sample. The group therapy program (10 two-hour weekly sessions) was examined in a single-arm, before-after pilot trial, conducted in a behavioural health clinic in Adelaide, Australia. Primary outcomes included survey and assessment-based analyses of depression, anxiety, body image, self-esteem, and weight (kg), assessed at four time-points: baseline, post-intervention, three-months and 12-months post program. Eighteen participants (75%) completed the program and all assessments. RESULTS Significant improvements in depression, anxiety, self-esteem and body shape concern scores, several quality of life domains, eating behaviours and total physical activity (among others) - but not weight - were observed over the course of the trial. CONCLUSIONS Results from this pilot trial suggest that combining interventions for depression and obesity may be useful. Further development of the program, particularly regarding the potential for physical health benefits, and a randomised controlled trial, are warranted. TRIAL REGISTRATION Trial registration: ANZCTR, ACTRN12617001079336, 13 July 2017. Retrospectively registered after date of the first consent (6 July 2017), but before the date of the first intervention session (20 July 2017).

Methodological quality

Publication Type : Clinical Trial

Metadata